SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-24-000660
Filing Date
2024-02-02
Accepted
2024-02-02 17:00:18
Documents
20
Period of Report
2024-01-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cns_8k.htm   iXBRL 8-K 42460
2 PLACEMENT AGENT AGREEMENT cns_ex0101.htm EX-1.1 57820
3 FORM OF SERIES A COMMON WARRANT cns_ex0401.htm EX-4.1 106517
4 FORM OF SERIES B COMMON WARRANT cns_ex0402.htm EX-4.2 106937
5 FORM OF PRE-FUNDED WARRANT cns_ex0403.htm EX-4.3 103721
6 FORM OF SECURITIES PURCHASE AGREEMENT cns_ex1001.htm EX-10.1 287373
7 FORM OF AMENDMENT TO COMMON STOCK PURCHASE WARRANTS cns_ex1002.htm EX-10.2 18230
  Complete submission text file 0001683168-24-000660.txt   1056236

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE cnsp-20240129.xsd EX-101.SCH 3018
9 XBRL LABEL FILE cnsp-20240129_lab.xml EX-101.LAB 34240
10 XBRL PRESENTATION FILE cnsp-20240129_pre.xml EX-101.PRE 22361
21 EXTRACTED XBRL INSTANCE DOCUMENT cns_8k_htm.xml XML 3730
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

IRS No.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39126 | Film No.: 24592484
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)